Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07021040 · ClinicalTrials.gov registry record · NA
Olfactory Biopsies
A NA study of Alzheimer Disease and Smell Loss, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT07021040 is a NA study of Alzheimer Disease and Smell Loss that is actively recruiting participants, run by Duke University. The registered enrollment target is 125 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07021040, a NA study of Alzheimer Disease and Smell Loss, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study aims to investigate the function of the olfactory lining in the nasal cavity and its potential alterations in both healthy and diseased conditions. The olfactory lining is involved in the sense of smell. The purpose of this study is to collect tissue from the nasal cavity.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST olfactory testing
- OTHER Odor stimulation
- PROCEDURE Olfactory biopsy
Study Locations (1)
North Carolina
- Duke University Health Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2025-01-06 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07021040
The ClinicalTrials.gov registry entry for NCT07021040 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (95% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 3 interventions - of which olfactory testing is the first listed.
NCT07021040 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT07021040 about?
NCT07021040 is a clinical study titled "Olfactory Biopsies". This research study aims to investigate the function of the olfactory lining in the nasal cavity and its potential alterations in both healthy and diseased conditions. The olfactory lining is involved in the sense of smell. The purpose of this study is to collect tissue from the nasal cavity.
What is the current status of trial NCT07021040?
This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2025-01-06. Estimated completion is 2028-12-31.
What conditions does trial NCT07021040 study?
This clinical trial studies the following conditions: Alzheimer Disease, Smell Loss, Smell Dysfunction.
What interventions are being tested in trial NCT07021040?
The interventions under investigation include: olfactory testing (DIAGNOSTIC_TEST), Odor stimulation (OTHER), Olfactory biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT07021040?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07021040 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.